Daniel Faga is the President and CEO of AnaptysBio, Inc., a biotech company known for developing innovative treatments. He has a solid educational background with a B.S. in Engineering and an M.B.A. in Healthcare Management. Faga stepped into the CEO...
Daniel Faga is the President and CEO of AnaptysBio, Inc., a biotech company known for developing innovative treatments. He has a solid educational background with a B.S. in Engineering and an M.B.A. in Healthcare Management. Faga stepped into the CEO role in 2023 after serving as Interim President since March 2022. His experience spans over 20 years in the life sciences sector, where he held positions such as Chief Operating Officer at Mirati Therapeutics and Chief Business Officer at Spark Therapeutics. Under his leadership, AnaptysBio focuses on creating groundbreaking therapies, particularly for inflammation and immune-related conditions. Notably, his compensation package includes a $1.5 million transition bonus, which reflects a strong financial incentive tied to performance metrics.